Search alternatives:
treatment decreased » treatment increases (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
mean decrease » a decrease (Expand Search)
i decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
treatment decreased » treatment increases (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
mean decrease » a decrease (Expand Search)
i decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count.
Published 2025“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
-
149
-
150
Decreased AMPKα expression in <i>NGLY1</i> deficiency patient fibroblasts and rescue of impaired cellular respiration in these cells by PT1 treatment.
Published 2020“…<p>(A) qRT-PCR assays show a significant decrease in the mRNA levels of <i>AMPKα1</i> and <i>AMPKα2</i> in two different <i>NGLY1</i> deficiency patient fibroblasts compared to control (<i>NGLY1</i><sup><i>+/+</i></sup>) and two different parents (<i>NGLY1</i><sup><i>+/–</i></sup>) fibroblasts. …”
-
151
-
152
Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity.
Published 2024“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”
-
153
-
154
Annual number of outpatient visits in recurrence and non-recurrence groups.
Published 2025Subjects: -
155
-
156
-
157
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025Subjects: -
158
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025Subjects: -
159
-
160